Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
163045 ARTíCULOS , VIENDO DEL 64561 AL 64575
[Biological markers for early diagnosis of Alzheimer's disease]
Taniguchi M, Urakami K.
Rinsho Byori. 2014 Mar;62(3):261-6.
0
0
0
Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents
Ambure P, Roy K.
Expert Opin Drug Discov. 2014 Jun;9(6):697-723. doi: 10.1517/17460441.2014.909404. Epub 2014 Apr 23.
0
0
0
Alzheimer's and Parkinson's diseases: an environmental proteomic point of view
Demartini DR, Schilling LP, da Costa JC, Carlini CR.
J Proteomics. 2014 Jun 2;104:24-36. doi: 10.1016/j.jprot.2014.04.014. Epub 2014 Apr 18.
0
0
0
Cerebrospinal fluid biomarkers of Alzheimer's disease
Sui X, Liu J, Yang X.
Neurosci Bull. 2014 Apr;30(2):233-42. doi: 10.1007/s12264-013-1412-1. Epub 2014 Apr 15.
0
0
0
Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease
Tian T, Zhang B, Jia Y, Li Z.
Dis Markers. 2014;2014:826503. doi: 10.1155/2014/826503. Epub 2014 Feb 12.
0
0
0
Hertze J, Nägga K, Minthon L, Hansson O.
BMC Neurol. 2014 Apr 1;14:64. doi: 10.1186/1471-2377-14-64.
0
0
0
[Biomarkers in Alzheimer's disease]
García-Ribas G, López-Sendón Moreno JL, García-Caldentey J.
Rev Neurol. 2014 Apr 1;58(7):308-17.
0
0
0
Biological markers of Alzheimer's disease
de Souza LC, Sarazin M, Teixeira-Júnior AL, Caramelli P, Santos AE, Dubois B.
Arq Neuropsiquiatr. 2014 Mar;72(3):227-31. doi: 10.1590/0004-282x20130233.
0
0
0
Hori K, Konishi K, Tani M, Tomioka H, Akita R, Kitajima Y, Aoki M, Yokoyama S, Azuma K, Ikuse D, Akashi N, Hosoi M, Jinbo K, Hachisu M.
Dis Markers. 2014;2014:459013. doi: 10.1155/2014/459013. Epub 2014 Feb 9.
0
0
0
Post-translational modifications in Alzheimer's disease and the potential for new biomarkers
Russell CL, Koncarevic S, Ward MA.
J Alzheimers Dis. 2014;41(2):345-64. doi: 10.3233/JAD-132312.
0
0
0
Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications
Bagnoli S, Piaceri I, Sorbi S, Nacmias B.
Neurodegener Dis Manag. 2014;4(1):73-81. doi: 10.2217/nmt.13.68.
0
0
0
Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders
Patel S.
Adv Protein Chem Struct Biol. 2014;94:39-75. doi: 10.1016/B978-0-12-800168-4.00003-2.
0
0
0
Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms
Kitzlerová E, Fisar Z, Jirák R, Zvĕrová M, Hroudová J, Benaková H, Raboch J.
Neuro Endocrinol Lett. 2014;35(1):42-9.
0
0
0
[Depression or Alzheimer-type dementia?]
Bystad M, Pettersen K, Grønli OK.
Tidsskr Nor Laegeforen. 2014 Mar 11;134(5):525-8. doi: 10.4045/tidsskr.13.0364. eCollection 2014 Mar 11.
0
0
0
Furman CD, Earnshaw LA, Doukas DJ, Farrer LA, Friedland RP.
Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):590-5. doi: 10.1177/1533317514525829. Epub 2014 Mar 10.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
